Corvus Pharmaceuticals, Inc. (CRVS) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kronos Bio, Inc.

DURECT Corp.

FibroGen, Inc.

Alpha Teknova, Inc.

Ocuphire Pharma, Inc.

G1 Therapeutics, Inc.

Capricor Therapeutics, Inc.

Corvus Pharmaceuticals, Inc.

Immix Biopharma, Inc.

Werewolf Therapeutics, Inc.

Evelo Biosciences, Inc.

Why is Corvus Pharmaceuticals, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Corvus Pharmaceuticals, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Corvus Pharmaceuticals, Inc.

184.22%

2.92

183.20%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

2.70%

EBIT to Interest (avg)

-46.34

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.89

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

72.79%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

18.40

EV to EBIT

-32.30

EV to EBITDA

-32.38

EV to Capital Employed

194.34

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-601.72%

ROE (Latest)

-55.55%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -20.17 MM

ROCE(HY)

Highest at -35.82%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-20What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD -32.07 MM

OPERATING PROFIT(Q)

Lowest at USD -10.54 MM

PRE-TAX PROFIT(Q)

Lowest at USD -10.16 MM

NET PROFIT(Q)

Lowest at USD -10.16 MM

Here's what is working for Corvus Pharmaceuticals, Inc.

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Corvus Pharmaceuticals, Inc.

Operating Profit

Lowest at USD -10.54 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -10.16 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -10.16 MM has Fallen at -37.8%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -10.16 MM has Fallen at -37.8%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -32.07 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Profit

Lowest at USD -10.16 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)